News

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.
Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...
The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
The world's first mRNA vaccine against Elephant Endotheliotropic Herpesvirus (EEHV) has reportedly shown promising results, ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Elephant calves at Cincinnati Zoo develop strong antibody responses against EEHV after receiving an innovative mRNA vaccine.
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best CRISPR stocks to buy. On June 23, H.C. Wainwright maintained its ...
Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.